FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

BBL CRYSTAL MRSA ID SYSTEM

K Number: K926294 · Decision May 18, 1993
Classifications
1
FEI Numbers
9
Registration Numbers
9
Same Product Code
440
Applicant Total
33
Review Days
155

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
BBL CRYSTAL MRSA ID SYSTEM
K Number
K926294
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.1640
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Becton Dickinson Microbiology Systems
Date Received
December 14, 1992
Decision Date
May 18, 1993
Product Code
JWY
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
JWY Manual Antimicrobial Susceptibility Test Systems

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (JWY), ordered by most recent decision date.

View all

Other Clearances by Becton Dickinson Microbiology Systems

K Number Device Name
K993577 CEFOTAXIME/CLAVULANIC, 30/10UG, BBL SENSI-DISC AND CEFTAZIDIME/CLAVULANIC ACID, 30/10UG, BBL SENSI-DISC
K984631 BDPROBETEC ET CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE AMPLIFIED DNA ASSAY
K981517 CEFDINIR, 5 UG, SENSI-DISC
K980683 TROVAFLOXACIN 10G, SENSI-DISC
K974578 GREPAFLOXACIN, 5 MG, SENSI-DISC
K970333 BACTEC MYCO/F LYTIC CULTURE VIALS
K970512 BACTEC MYCO/F LYTIC CULTURE VIALS
K972758 BACTEC MYCO/F-SPUTA CULTURE VIALS
K972098 FOSFOMYCIN, 200 MG, SENSI-DISC
K970385 SPARFLOZACIN, 5 MCG, SENSI-DISC
Search all 33 clearances from Becton Dickinson Microbiology Systems →